CD200+ cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti-PD-1/PD-L1 therapy.
Wang X, Zha H, Wu W, Yuan T, Xie S, Jin Z, Long H, Yang F, Wang Z, Zhang A, Gao J, Jiang Y, Wang L, Hu C, Wan YY, Li QJ, Symonds ALJ, Jia Q, Zhu B.
Wang X, et al.
Sci Transl Med. 2023 Jan 18;15(679):eabn5029. doi: 10.1126/scitranslmed.abn5029. Epub 2023 Jan 18.
Sci Transl Med. 2023.
PMID: 36652534